|
PEX3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.73256980878978E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.03304040269359E-12 |
| Normal-vs-Stage2 |
1.54090000004103E-06 |
| Normal-vs-Stage3 |
9.80530000527224E-08 |
| Normal-vs-Stage4 |
2.85280021827816E-10 |
| Stage1-vs-Stage2 |
7.167200E-01 |
| Stage1-vs-Stage3 |
7.317800E-01 |
| Stage1-vs-Stage4 |
7.157900E-03 |
| Stage2-vs-Stage3 |
5.478400E-01 |
| Stage2-vs-Stage4 |
2.260100E-02 |
| Stage3-vs-Stage4 |
7.251900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73006053927338E-12 |
| Normal-vs-AfricanAmerican |
1.22150001224952E-09 |
| Normal-vs-Asian |
9.203700E-02 |
| Caucasian-vs-AfricanAmerican |
2.115400E-01 |
| Caucasian-vs-Asian |
9.396200E-01 |
| AfricanAmerican-vs-Asian |
6.328000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.02251540567977E-13 |
| Normal-vs-Female |
8.16330003594601E-10 |
| Male-vs-Female |
1.704050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.88900031569983E-11 |
| Normal-vs-Extreme_Weight |
1.62636570877339E-12 |
| Normal-vs-Obese |
2.75639955304996E-10 |
| Normal-vs-Extreme_Obese |
5.131800E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.295600E-01 |
| Normal_Weight-vs-Obese |
2.895800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.545560E-01 |
| Extreme_Weight-vs-Obese |
6.338200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.223500E-02 |
| Obese-vs-Extreme_Obese |
2.964000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.4703000001125E-07 |
| Normal-vs-Age(41-60Yrs) |
4.2007508582742E-12 |
| Normal-vs-Age(61-80Yrs) |
1.31894495325469E-13 |
| Normal-vs-Age(81-100Yrs) |
4.06879996361909E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.735000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.193000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.723000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.918000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.427440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.122600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.68809410894255E-12 |
| Normal-VS-Type2 PRCC |
4.12570000385415E-08 |
| Normal-VS-KIRP CIMP |
2.36830000055477E-07 |
| Normal-VS-Unclassified PRCC |
1.85350002013251E-09 |
| Type1 PRCC-VS-Type2 PRCC |
1.600580E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.366400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.566400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.630600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.938200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.388600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.41459999269955E-09 |
| Normal-vs-N1 |
1.73220326971091E-11 |
| Normal-vs-N2 |
2.51799999961833E-07 |
| N0-vs-N1 |
5.506800E-01 |
| N0-vs-N2 |
1.497040E-01 |
| N1-vs-N2 |
4.568400E-02 |
|
|
